What is the current regulatory stance on direct-to-consumer telehealth platforms that allow patients to independently order lipid panels and HbA1c blood tests without a primary care physician consultation?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What is the current regulatory stance on direct-to-consumer telehealth platforms that allow patients to independently order lipid panels and HbA1c blood tests without a primary care physician consultation?
4 real searches · 1 real-search pass
United States direct access testing state laws CLIA consumer ordered laboratory tests lipid panel HbA1c 2026 regulatoryGoogle ↗
OBSERVED
CMS CLIA direct access testing patient ordered tests state law laboratory regulationGoogle ↗
OBSERVED
New York direct access testing patient ordered laboratory tests physician order lawGoogle ↗
OBSERVED
FDA laboratory developed tests rule status 2025 2026 vacated court CLIAGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 4 queries…
Searches and sources
ChatGPT4 real searches · gpt-6
United States direct access testing state laws CLIA consumer ordered laboratory tests lipid panel HbA1c 2026 regulatory Google ↗
CMS CLIA direct access testing patient ordered tests state law laboratory regulation Google ↗
New York direct access testing patient ordered laboratory tests physician order law Google ↗
FDA laboratory developed tests rule status 2025 2026 vacated court CLIA Google ↗
- Clinical Laboratory Improvement Amendments (CLIA) · fda.gov
- Consumer Services and Healthcare Regulation: Frequently Asked Questions (FAQs) · in.gov
- Policy Statement · ascp.org
- Laboratory Developed Tests · fda.gov
- DEPARTMENT OF HEALTH AND HUMAN SERVICES · public-inspection.federalregister.gov
- Direct Access Testing · cdc.gov
- Direct-to-consumer laboratory testing · myadlm.org
- NYS Open Legislation · nysenate.gov
- Direct Access Testing | New York State Department of Health, Wadsworth Center · d1sct9vy9n375u.cloudfront.net
- NY State Senate Bill 2025-S9172 · nysenate.gov
- STATE OF NEW YORK · legislation.nysenate.gov
- Test Approval | New York State Department of Health, Wadsworth Center · d1sct9vy9n375u.cloudfront.net
Queries
4 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
United States direct access testing state laws CLIA consumer ordered laboratory tests lipid panel HbA1c 2026 regulatory OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
CMS CLIA direct access testing patient ordered tests state law laboratory regulation OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
New York direct access testing patient ordered laboratory tests physician order law OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
FDA laboratory developed tests rule status 2025 2026 vacated court CLIA OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |